These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 3070641)
21. [Study of circulating immunoblasts in the peripheral blood of patients with systemic lupus erythematosus and other rheumatic diseases]. Bulanova TD; le Go A; Alekberova ZS; Polianskaia IP Ter Arkh; 1980; 52(6):64-7. PubMed ID: 6967635 [No Abstract] [Full Text] [Related]
22. [Pathogenesis of systemic scleroderma: immunological aspects]. Mouthon L; García De La Peña-Lefebvre P; Chanseaud Y; Tamby MC; Boissier MC; Guillevin L Ann Med Interne (Paris); 2002 May; 153(3):167-78. PubMed ID: 12218899 [TBL] [Abstract][Full Text] [Related]
23. Unusual case of progressive systemic sclerosis with onset in early childhood and following infectious mononucleosis. Urano J; Kohno H; Watanabe T Eur J Pediatr; 1981 Jul; 136(3):285-9. PubMed ID: 6973466 [TBL] [Abstract][Full Text] [Related]
24. [Surface markers of peripheral blood T- and B-lymphocytes in patients with rheumatoid diseases]. Stankaitene DI; Redaitene EI; Rulis AK; Ianulevichiute NA Ter Arkh; 1981; 53(7):6-11. PubMed ID: 7027511 [No Abstract] [Full Text] [Related]
25. [Immunological disorders in testicular torsion in children]. Tereshchenko AV; Chernyshov VP; Zinchenko AN; Galanina IK Vestn Khir Im I I Grek; 1986 May; 136(5):103-5. PubMed ID: 3489311 [No Abstract] [Full Text] [Related]
26. Evidence for cell-mediated immunity to collagen in progressive systemic sclerosis. Stuart JM; Postlethwaite AE; Kang AH J Lab Clin Med; 1976 Oct; 88(4):601-7. PubMed ID: 965811 [TBL] [Abstract][Full Text] [Related]
30. [Quantitative evaluation of T-, B- and 0-lymphocyte populations in focal scleroderma]. Fedorova EG Vestn Dermatol Venerol; 1980 Jun; (6):17-9. PubMed ID: 6967244 [No Abstract] [Full Text] [Related]
31. [Cellular hypersensitivity in some therapeutic diseases]. Traianova TG Ter Arkh; 1977; 49(7):11-20. PubMed ID: 302502 [No Abstract] [Full Text] [Related]
32. Pathogenesis of scleroderma: the interrelationship of the immune and vascular hypotheses. Sternberg EM Surv Immunol Res; 1985; 4(1):69-80. PubMed ID: 3890057 [No Abstract] [Full Text] [Related]
33. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets. Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321 [TBL] [Abstract][Full Text] [Related]
34. [Autoimmune pathology of the oral cavity]. Fustini F; Montanari G Minerva Stomatol; 1981; 30(1):21-7. PubMed ID: 6971396 [No Abstract] [Full Text] [Related]
35. A brief overview of the pathogenesis of scleroderma (systemic sclerosis). LeRoy EC Ann Rheum Dis; 1992 Feb; 51(2):286-8. PubMed ID: 1550420 [No Abstract] [Full Text] [Related]
36. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma]. Onisk Z; Tchórzewski H Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955 [No Abstract] [Full Text] [Related]